Generic Drug Name |
Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 23 Vaccine Polyvalent | Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free |
Features and Benefits |
|
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
- Store unopened and opened vials at 2° - 8°C (36° - 46°F)
|
|
- VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
- Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
- Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
- 10 Per Package
|
- In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
- In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
- No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
- In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
- In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
- The tip cap and rubber plunger of the prefilled syringe do not contain latex
- Store Refrigerated at 2° to 8°C (36° to 46°F)
|